All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

93

Reset

93 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • RilvegostomigAZD2936Phase 325 trials

    AstraZeneca · Biliary Tract Cancer, Gastric Cancer, Non-small Cell Lung Cancer

  • FianlimabREGN3767Phase 311 trials

    Regeneron · Melanoma, Non-small Cell Lung Cancer, Hepatocellular Carcinoma

  • IfebemtinibIN10018, BI853520Phase 311 trials

    InxMed (Shanghai) Co., Ltd. · Solid Tumor, NSCLC, Solid Tumor Cancer

  • LBL-024Phase 311 trials

    Nanjing Leads Biolabs Co.,Ltd · Advanced Solid Tumour, Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Colorectal Carcinoma

  • Intismeran autogeneV940, mRNA-4157Phase 310 trials

    Merck & Co. · Non-small Cell Lung Cancer, Melanoma, Bladder Cancer

  • L19TNFL19IL2, OnfekafuspPhase 310 trials

    Philogen S.p.A. · Glioblastoma, Locally Advanced Basal Cell Carcinoma, Melanoma Stage III

  • FavezelimabMK-4280, MK-4820APhase 39 trials

    Merck & Co. · Melanoma, Carcinoma, Renal Cell, Solid Tumors

  • TucidinostatChidamide, HBI-8000Phase 39 trials

    Chipscreen Biosciences, Ltd. · Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy, Unresectable or Metastatic Melanoma, Progressive Brain Metastasis

  • IBI363Phase 37 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Melanoma, Colorectal Cancer, Resectable Stage II-III Non-small Cell Lung Cancer

  • OH2Phase 36 trials

    Binhui Biopharmaceutical Co., Ltd. · Melanoma, Solid Tumor, Gastrointestinal Cancer

  • PucotenlimabHX008Phase 36 trials

    Lepu Biopharma Co., Ltd. · Head and Neck Squamous Cell Carcinoma, Melanoma, Hepatocellular Carcinoma

  • CeralasertibAZD6738Phase 35 trials

    AstraZeneca · Melanoma, Advanced or Metastatic NSCLC, Non-Small Cell Lung Cancer

  • DarovasertibIDE 196, LXS196Phase 35 trials

    IDEAYA Biosciences · Uveal Melanoma, Metastatic Uveal Melanoma, Cutaneous Melanoma

  • ONC-392Gotistobart, BNT316Phase 35 trials

    OncoC4, Inc. · Non Small Cell Lung Cancer, Ovarian Cancer, Advanced Solid Tumor

  • rHuPH20Phase 35 trials

    Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma

  • AtebimetinibIMM-1-104, Group APhase 34 trials

    Immuneering Corporation · Pancreatic Adenocarcinoma, Advanced Solid Tumor, Malignant Melanoma (Cutaneous)

  • GimistotugBGB-A445Phase 34 trials

    BeOne Medicines (BeiGene) · Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma

  • EIK1001Phase 33 trials

    Eikon Therapeutics · Advanced Melanoma, NSCLC, Non Small Cell Lung Cancer (Squamous or Non Squamous)

  • IO102-IO103Phase 33 trials

    IO Biotech · Metastatic Melanoma, Unresectable Melanoma, Melanoma

  • ABP 206Phase 32 trials

    Amgen · Melanoma

  • anzutresgene autoleucelIMA203 Product, IMA203 product- flat dosePhase 32 trials

    Immatics US, Inc. · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult

  • AU-011Bel-sarPhase 32 trials

    Aura Biosciences · Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma

  • BCD-217Phase 32 trials

    Biocad · Melanoma Stage III, Melanoma (Skin), Melanoma

  • BrenetafuspIMC-F106CPhase 32 trials

    Immunocore Ltd · Select Advanced Solid Tumors, Advanced Melanoma

  • CobolimabPhase 32 trials

    GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma

  • NaporafenibLXH254, ERAS-254Phase 32 trials

    Novartis · Melanoma, Advanced or Metastatic NRAS-mutant Melanoma

  • RP2Phase 32 trials

    Replimune, Inc. · Hepatocellular Carcinoma, Biliary Tract Cancer, Metastatic Uveal Melanoma

  • TunlametinibPhase 32 trials

    Shanghai Kechow Pharma, Inc. · Colorectal Cancer Metastatic, Melanoma

  • Amgen · Melanoma

  • Amgen · Melanoma

  • Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • LNS8801Phase 31 trial

    Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • MB11Proposed Nivolumab BiosimilarPhase 31 trial

    mAbxience Research S.L. · Advanced (Unresectable or Metastatic) Melanoma

  • Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • prolgolimabBCD-100, FortecaPhase 31 trial

    Biocad · Melanoma, Melanoma (Skin), Melanoma Stage III

  • MK-4830Phase 210 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma

  • BL-M08D1Phase 26 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gastrointestinal Tumors, Diffuse Large B-Cell Lymphoma

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • VibostolimabMK-7684Phase 26 trials

    Merck & Co. · Melanoma, Carcinoma, Non-Small-Cell Lung, Metastatic Urothelial Carcinoma

  • APG-115Phase 24 trials

    Ascentage Pharma Group Inc. · T-Prolymphocytic Leukemia, Non-Hodgkins Lymphoma, Liposarcoma

  • RO7198457Autogene CevumeranPhase 24 trials

    Roche (Genentech) · Colorectal Cancer Stage II, Colorectal Cancer Stage III, Adenocarcinoma, Pancreatic Ductal

  • T3011Phase 24 trials

    Shanghai Pharmaceuticals Holding Co., Ltd · Advanced Solid Tumors, Nonmuscle-invasive Bladder Cancer, Solid Tumor

  • INCAGN02385Phase 23 trials

    Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer

  • INCAGN02390Phase 23 trials

    Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer

  • PD-L1 t-haNKPhase 23 trials

    ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • REGN10597PD-1-IL2Ra-IL2 immunotherapyPhase 23 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • roginolisibIOA-244Phase 23 trials

    iOnctura · Myelofibrosis (MF), Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLC

  • ST-1898Phase 23 trials

    Beijing Scitech-Mq Pharmaceuticals Limited · Advanced Renal Cell Carcinoma, Differentiated Thyroid Carcinoma, Unresectable or Metastatic Melanoma

  • Shanghai Juncell Therapeutics · Non Small Cell Lung Cancer, Melanoma

  • BelvarafenibHM95573Phase 22 trials

    Hanmi Pharmaceutical Company Limited · Advanced or Metastatic Melanoma, Solid Tumors

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.